Karyopharm Therapeutics Enters Restructuring Agreement With Lenders, Clearing Path For A Merger With Ayrmid; Secures Commitments For Up To $55M Of Debtor-In-Possession Financing

Benzinga

2026.11.02 12:16 (GMT+0)

Abrir em Benzinga